I am a gastroenterologist with a clinical and research focus in hereditary gastrointestinal cancer syndromes, and I have the honor and privilege off of serving as the Director of the Gastrointestinal Cancer Genetics Program at the University of Pennsylvania and the Abramson Cancer Center. Throughout my career and in my work in cancer genetics, one thing is clear: Pancreatic cancer is a devastating malignancy. I see patients every week who are battling this disease, who have family members who are battling or have battled this disease, or who have a hereditary genetic predisposition syndrome that increases their own risk of pancreatic cancer. The need for more research is clear. The need for more effective therapies is clear. The need for better early detection and risk stratification is clear.
I'm running the NYC half marathon on behalf of Project Purple to help raise money to help fund research to advance the field of pancreatic cancer. Of special interest to me is Project Purple's generous support of the PRECEDE Consortium, which is a new international consortium dedicated to improving the early detection of pancreatic cancer, and of which I am involved.
We can do better in the fight against pancreatic cancer. Please support my run to help with this effort.
To learn more about the Gastrointestinal Cancer Genetics Program at the University of Pennsylvania/Abramson Cancer Center and ongoing research studies please visit www.pennmedicine.org/GICancerGenetics